News
Glucagon-like peptide-1 receptor agonists (GLP-1 ... differences between them. GLP-1 RAs are classified as short-acting or long-acting, depending on how long they work in your body.
6h
Lose It! on MSNHow to Inject Yourself With GLP-1 MedicationsIt’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with ...
Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...
People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...
The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
GLP-1 receptor agonists are effective weight-loss medications, but they may also decrease muscle mass, raising concerns about ...
The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.
Doctors believe that GLP-1 agonists work by binding to receptors that tell ... "Of course, one caveat is that we do not know the effects of this newer therapy on cardiovascular outcomes but ...
“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
4d
News-Medical.Net on MSNBody image concerns drive interest in GLP-1 weight loss drugs, study findsA new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results